Global Liraglutide

Liraglutide Comprehensive Study by Application (Hospital, Clinics, Drug Store), Forms (Pills, Liquid), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2026

Liraglutide Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Liraglutide Market?

Overweight and obesity lead to numerous adverse conditions including type 2 diabetes, cardiovascular disease, stroke, and certain cancers. The worldwide spread of obesity and associated comorbidities not only threatens quality of life but also presents a significant economic burden. Liraglutide helps to induce and sustain weight loss in patients with obesity. Its efficacy is comparable to other available agents but it offers the unique benefit of improved glycemic control. Liraglutide should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Liraglutide is not a substitute for insulin.

The market study is being classified, by Application (Hospital, Clinics and Drug Store) and major geographies with country level break-up.

HEC Pharm (China), Teva (Israel), Bachem (Switzerland), Bharat Pharmaceuticals (India), Shenzhen JYMed Technology (China), WuXi AppTec Co., Ltd. (China), AmbioPharm, Inc (United States), Rochem International Inc. (United States), ALP Pharm (China) and Viruj Pharma (India) are some of the key players profiled in the study.

Key players are implementing various strategies such as new product development, joint ventures, partnerships and others. Medical technology and healthcare companies are setting standards by manufacturing liraglutide with the help of various technological advancements. Research Analyst at AMA predicts that Chinese Vendors will contribute to the maximum growth of Global Liraglutide market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Liraglutide market by Type, Application and Region.

On the basis of geography, the market of Liraglutide has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing preference for health care

Market Trend
  • Upgradation in the medical treatments

Restraints
  • Over dosage of liraglutide might result in the occurrence if tumors in thyroid glands

Opportunities
  • Increasing demand from developing countries such as India and China

Challenges
  • Lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose





Key Target Audience
Suppliers of medicines, Wholesalers, distributers and retailers of medicines., Health Care industry, Pharmaceutical Industry, Laboratory, Government Bodies and Others

Report Objectives / Segmentation Covered

By Application
  • Hospital
  • Clinics
  • Drug Store
By Forms
  • Pills
  • Liquid

By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing preference for health care
    • 3.3. Market Challenges
      • 3.3.1. Lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose
    • 3.4. Market Trends
      • 3.4.1. Upgradation in the medical treatments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Liraglutide, by Application, Forms, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Liraglutide (Value)
      • 5.2.1. Global Liraglutide by: Application (Value)
        • 5.2.1.1. Hospital
        • 5.2.1.2. Clinics
        • 5.2.1.3. Drug Store
      • 5.2.2. Global Liraglutide by: Forms (Value)
        • 5.2.2.1. Pills
        • 5.2.2.2. Liquid
      • 5.2.3. Global Liraglutide by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Liraglutide Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Liraglutide (Volume)
      • 5.3.1. Global Liraglutide by: Application (Volume)
        • 5.3.1.1. Hospital
        • 5.3.1.2. Clinics
        • 5.3.1.3. Drug Store
      • 5.3.2. Global Liraglutide by: Forms (Volume)
        • 5.3.2.1. Pills
        • 5.3.2.2. Liquid
      • 5.3.3. Global Liraglutide by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Liraglutide Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Liraglutide (Price)
  • 6. Liraglutide: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. HEC Pharm (China)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Teva (Israel)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bachem (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bharat Pharmaceuticals (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Shenzhen JYMed Technology (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. WuXi AppTec Co., Ltd. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. AmbioPharm, Inc (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Rochem International Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ALP Pharm (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Viruj Pharma (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Liraglutide Sale, by Application, Forms, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Liraglutide (Value)
      • 7.2.1. Global Liraglutide by: Application (Value)
        • 7.2.1.1. Hospital
        • 7.2.1.2. Clinics
        • 7.2.1.3. Drug Store
      • 7.2.2. Global Liraglutide by: Forms (Value)
        • 7.2.2.1. Pills
        • 7.2.2.2. Liquid
      • 7.2.3. Global Liraglutide by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Liraglutide Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Liraglutide (Volume)
      • 7.3.1. Global Liraglutide by: Application (Volume)
        • 7.3.1.1. Hospital
        • 7.3.1.2. Clinics
        • 7.3.1.3. Drug Store
      • 7.3.2. Global Liraglutide by: Forms (Volume)
        • 7.3.2.1. Pills
        • 7.3.2.2. Liquid
      • 7.3.3. Global Liraglutide by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Liraglutide Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Liraglutide (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Liraglutide: by Application(USD Million)
  • Table 2. Liraglutide Hospital , by Region USD Million (2015-2020)
  • Table 3. Liraglutide Clinics , by Region USD Million (2015-2020)
  • Table 4. Liraglutide Drug Store , by Region USD Million (2015-2020)
  • Table 5. Liraglutide: by Forms(USD Million)
  • Table 6. Liraglutide Pills , by Region USD Million (2015-2020)
  • Table 7. Liraglutide Liquid , by Region USD Million (2015-2020)
  • Table 8. Liraglutide: by Distribution Channel(USD Million)
  • Table 9. Liraglutide Online , by Region USD Million (2015-2020)
  • Table 10. Liraglutide Offline , by Region USD Million (2015-2020)
  • Table 11. South America Liraglutide, by Country USD Million (2015-2020)
  • Table 12. South America Liraglutide, by Application USD Million (2015-2020)
  • Table 13. South America Liraglutide, by Forms USD Million (2015-2020)
  • Table 14. South America Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 15. Brazil Liraglutide, by Application USD Million (2015-2020)
  • Table 16. Brazil Liraglutide, by Forms USD Million (2015-2020)
  • Table 17. Brazil Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 18. Argentina Liraglutide, by Application USD Million (2015-2020)
  • Table 19. Argentina Liraglutide, by Forms USD Million (2015-2020)
  • Table 20. Argentina Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 21. Rest of South America Liraglutide, by Application USD Million (2015-2020)
  • Table 22. Rest of South America Liraglutide, by Forms USD Million (2015-2020)
  • Table 23. Rest of South America Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 24. Asia Pacific Liraglutide, by Country USD Million (2015-2020)
  • Table 25. Asia Pacific Liraglutide, by Application USD Million (2015-2020)
  • Table 26. Asia Pacific Liraglutide, by Forms USD Million (2015-2020)
  • Table 27. Asia Pacific Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 28. China Liraglutide, by Application USD Million (2015-2020)
  • Table 29. China Liraglutide, by Forms USD Million (2015-2020)
  • Table 30. China Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 31. Japan Liraglutide, by Application USD Million (2015-2020)
  • Table 32. Japan Liraglutide, by Forms USD Million (2015-2020)
  • Table 33. Japan Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 34. India Liraglutide, by Application USD Million (2015-2020)
  • Table 35. India Liraglutide, by Forms USD Million (2015-2020)
  • Table 36. India Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 37. South Korea Liraglutide, by Application USD Million (2015-2020)
  • Table 38. South Korea Liraglutide, by Forms USD Million (2015-2020)
  • Table 39. South Korea Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 40. Taiwan Liraglutide, by Application USD Million (2015-2020)
  • Table 41. Taiwan Liraglutide, by Forms USD Million (2015-2020)
  • Table 42. Taiwan Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 43. Australia Liraglutide, by Application USD Million (2015-2020)
  • Table 44. Australia Liraglutide, by Forms USD Million (2015-2020)
  • Table 45. Australia Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 46. Rest of Asia-Pacific Liraglutide, by Application USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Liraglutide, by Forms USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 49. Europe Liraglutide, by Country USD Million (2015-2020)
  • Table 50. Europe Liraglutide, by Application USD Million (2015-2020)
  • Table 51. Europe Liraglutide, by Forms USD Million (2015-2020)
  • Table 52. Europe Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 53. Germany Liraglutide, by Application USD Million (2015-2020)
  • Table 54. Germany Liraglutide, by Forms USD Million (2015-2020)
  • Table 55. Germany Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 56. France Liraglutide, by Application USD Million (2015-2020)
  • Table 57. France Liraglutide, by Forms USD Million (2015-2020)
  • Table 58. France Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 59. Italy Liraglutide, by Application USD Million (2015-2020)
  • Table 60. Italy Liraglutide, by Forms USD Million (2015-2020)
  • Table 61. Italy Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 62. United Kingdom Liraglutide, by Application USD Million (2015-2020)
  • Table 63. United Kingdom Liraglutide, by Forms USD Million (2015-2020)
  • Table 64. United Kingdom Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 65. Netherlands Liraglutide, by Application USD Million (2015-2020)
  • Table 66. Netherlands Liraglutide, by Forms USD Million (2015-2020)
  • Table 67. Netherlands Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 68. Rest of Europe Liraglutide, by Application USD Million (2015-2020)
  • Table 69. Rest of Europe Liraglutide, by Forms USD Million (2015-2020)
  • Table 70. Rest of Europe Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 71. MEA Liraglutide, by Country USD Million (2015-2020)
  • Table 72. MEA Liraglutide, by Application USD Million (2015-2020)
  • Table 73. MEA Liraglutide, by Forms USD Million (2015-2020)
  • Table 74. MEA Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 75. Middle East Liraglutide, by Application USD Million (2015-2020)
  • Table 76. Middle East Liraglutide, by Forms USD Million (2015-2020)
  • Table 77. Middle East Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 78. Africa Liraglutide, by Application USD Million (2015-2020)
  • Table 79. Africa Liraglutide, by Forms USD Million (2015-2020)
  • Table 80. Africa Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 81. North America Liraglutide, by Country USD Million (2015-2020)
  • Table 82. North America Liraglutide, by Application USD Million (2015-2020)
  • Table 83. North America Liraglutide, by Forms USD Million (2015-2020)
  • Table 84. North America Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 85. United States Liraglutide, by Application USD Million (2015-2020)
  • Table 86. United States Liraglutide, by Forms USD Million (2015-2020)
  • Table 87. United States Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 88. Canada Liraglutide, by Application USD Million (2015-2020)
  • Table 89. Canada Liraglutide, by Forms USD Million (2015-2020)
  • Table 90. Canada Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 91. Mexico Liraglutide, by Application USD Million (2015-2020)
  • Table 92. Mexico Liraglutide, by Forms USD Million (2015-2020)
  • Table 93. Mexico Liraglutide, by Distribution Channel USD Million (2015-2020)
  • Table 94. Liraglutide Sales: by Application(ml)
  • Table 95. Liraglutide Sales Hospital , by Region ml (2015-2020)
  • Table 96. Liraglutide Sales Clinics , by Region ml (2015-2020)
  • Table 97. Liraglutide Sales Drug Store , by Region ml (2015-2020)
  • Table 98. Liraglutide Sales: by Forms(ml)
  • Table 99. Liraglutide Sales Pills , by Region ml (2015-2020)
  • Table 100. Liraglutide Sales Liquid , by Region ml (2015-2020)
  • Table 101. Liraglutide Sales: by Distribution Channel(ml)
  • Table 102. Liraglutide Sales Online , by Region ml (2015-2020)
  • Table 103. Liraglutide Sales Offline , by Region ml (2015-2020)
  • Table 104. South America Liraglutide Sales, by Country ml (2015-2020)
  • Table 105. South America Liraglutide Sales, by Application ml (2015-2020)
  • Table 106. South America Liraglutide Sales, by Forms ml (2015-2020)
  • Table 107. South America Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 108. Brazil Liraglutide Sales, by Application ml (2015-2020)
  • Table 109. Brazil Liraglutide Sales, by Forms ml (2015-2020)
  • Table 110. Brazil Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 111. Argentina Liraglutide Sales, by Application ml (2015-2020)
  • Table 112. Argentina Liraglutide Sales, by Forms ml (2015-2020)
  • Table 113. Argentina Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 114. Rest of South America Liraglutide Sales, by Application ml (2015-2020)
  • Table 115. Rest of South America Liraglutide Sales, by Forms ml (2015-2020)
  • Table 116. Rest of South America Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 117. Asia Pacific Liraglutide Sales, by Country ml (2015-2020)
  • Table 118. Asia Pacific Liraglutide Sales, by Application ml (2015-2020)
  • Table 119. Asia Pacific Liraglutide Sales, by Forms ml (2015-2020)
  • Table 120. Asia Pacific Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 121. China Liraglutide Sales, by Application ml (2015-2020)
  • Table 122. China Liraglutide Sales, by Forms ml (2015-2020)
  • Table 123. China Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 124. Japan Liraglutide Sales, by Application ml (2015-2020)
  • Table 125. Japan Liraglutide Sales, by Forms ml (2015-2020)
  • Table 126. Japan Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 127. India Liraglutide Sales, by Application ml (2015-2020)
  • Table 128. India Liraglutide Sales, by Forms ml (2015-2020)
  • Table 129. India Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 130. South Korea Liraglutide Sales, by Application ml (2015-2020)
  • Table 131. South Korea Liraglutide Sales, by Forms ml (2015-2020)
  • Table 132. South Korea Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 133. Taiwan Liraglutide Sales, by Application ml (2015-2020)
  • Table 134. Taiwan Liraglutide Sales, by Forms ml (2015-2020)
  • Table 135. Taiwan Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 136. Australia Liraglutide Sales, by Application ml (2015-2020)
  • Table 137. Australia Liraglutide Sales, by Forms ml (2015-2020)
  • Table 138. Australia Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 139. Rest of Asia-Pacific Liraglutide Sales, by Application ml (2015-2020)
  • Table 140. Rest of Asia-Pacific Liraglutide Sales, by Forms ml (2015-2020)
  • Table 141. Rest of Asia-Pacific Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 142. Europe Liraglutide Sales, by Country ml (2015-2020)
  • Table 143. Europe Liraglutide Sales, by Application ml (2015-2020)
  • Table 144. Europe Liraglutide Sales, by Forms ml (2015-2020)
  • Table 145. Europe Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 146. Germany Liraglutide Sales, by Application ml (2015-2020)
  • Table 147. Germany Liraglutide Sales, by Forms ml (2015-2020)
  • Table 148. Germany Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 149. France Liraglutide Sales, by Application ml (2015-2020)
  • Table 150. France Liraglutide Sales, by Forms ml (2015-2020)
  • Table 151. France Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 152. Italy Liraglutide Sales, by Application ml (2015-2020)
  • Table 153. Italy Liraglutide Sales, by Forms ml (2015-2020)
  • Table 154. Italy Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 155. United Kingdom Liraglutide Sales, by Application ml (2015-2020)
  • Table 156. United Kingdom Liraglutide Sales, by Forms ml (2015-2020)
  • Table 157. United Kingdom Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 158. Netherlands Liraglutide Sales, by Application ml (2015-2020)
  • Table 159. Netherlands Liraglutide Sales, by Forms ml (2015-2020)
  • Table 160. Netherlands Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 161. Rest of Europe Liraglutide Sales, by Application ml (2015-2020)
  • Table 162. Rest of Europe Liraglutide Sales, by Forms ml (2015-2020)
  • Table 163. Rest of Europe Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 164. MEA Liraglutide Sales, by Country ml (2015-2020)
  • Table 165. MEA Liraglutide Sales, by Application ml (2015-2020)
  • Table 166. MEA Liraglutide Sales, by Forms ml (2015-2020)
  • Table 167. MEA Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 168. Middle East Liraglutide Sales, by Application ml (2015-2020)
  • Table 169. Middle East Liraglutide Sales, by Forms ml (2015-2020)
  • Table 170. Middle East Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 171. Africa Liraglutide Sales, by Application ml (2015-2020)
  • Table 172. Africa Liraglutide Sales, by Forms ml (2015-2020)
  • Table 173. Africa Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 174. North America Liraglutide Sales, by Country ml (2015-2020)
  • Table 175. North America Liraglutide Sales, by Application ml (2015-2020)
  • Table 176. North America Liraglutide Sales, by Forms ml (2015-2020)
  • Table 177. North America Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 178. United States Liraglutide Sales, by Application ml (2015-2020)
  • Table 179. United States Liraglutide Sales, by Forms ml (2015-2020)
  • Table 180. United States Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 181. Canada Liraglutide Sales, by Application ml (2015-2020)
  • Table 182. Canada Liraglutide Sales, by Forms ml (2015-2020)
  • Table 183. Canada Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 184. Mexico Liraglutide Sales, by Application ml (2015-2020)
  • Table 185. Mexico Liraglutide Sales, by Forms ml (2015-2020)
  • Table 186. Mexico Liraglutide Sales, by Distribution Channel ml (2015-2020)
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Liraglutide: by Application(USD Million)
  • Table 198. Liraglutide Hospital , by Region USD Million (2021-2026)
  • Table 199. Liraglutide Clinics , by Region USD Million (2021-2026)
  • Table 200. Liraglutide Drug Store , by Region USD Million (2021-2026)
  • Table 201. Liraglutide: by Forms(USD Million)
  • Table 202. Liraglutide Pills , by Region USD Million (2021-2026)
  • Table 203. Liraglutide Liquid , by Region USD Million (2021-2026)
  • Table 204. Liraglutide: by Distribution Channel(USD Million)
  • Table 205. Liraglutide Online , by Region USD Million (2021-2026)
  • Table 206. Liraglutide Offline , by Region USD Million (2021-2026)
  • Table 207. South America Liraglutide, by Country USD Million (2021-2026)
  • Table 208. South America Liraglutide, by Application USD Million (2021-2026)
  • Table 209. South America Liraglutide, by Forms USD Million (2021-2026)
  • Table 210. South America Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 211. Brazil Liraglutide, by Application USD Million (2021-2026)
  • Table 212. Brazil Liraglutide, by Forms USD Million (2021-2026)
  • Table 213. Brazil Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 214. Argentina Liraglutide, by Application USD Million (2021-2026)
  • Table 215. Argentina Liraglutide, by Forms USD Million (2021-2026)
  • Table 216. Argentina Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 217. Rest of South America Liraglutide, by Application USD Million (2021-2026)
  • Table 218. Rest of South America Liraglutide, by Forms USD Million (2021-2026)
  • Table 219. Rest of South America Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 220. Asia Pacific Liraglutide, by Country USD Million (2021-2026)
  • Table 221. Asia Pacific Liraglutide, by Application USD Million (2021-2026)
  • Table 222. Asia Pacific Liraglutide, by Forms USD Million (2021-2026)
  • Table 223. Asia Pacific Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 224. China Liraglutide, by Application USD Million (2021-2026)
  • Table 225. China Liraglutide, by Forms USD Million (2021-2026)
  • Table 226. China Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 227. Japan Liraglutide, by Application USD Million (2021-2026)
  • Table 228. Japan Liraglutide, by Forms USD Million (2021-2026)
  • Table 229. Japan Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 230. India Liraglutide, by Application USD Million (2021-2026)
  • Table 231. India Liraglutide, by Forms USD Million (2021-2026)
  • Table 232. India Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 233. South Korea Liraglutide, by Application USD Million (2021-2026)
  • Table 234. South Korea Liraglutide, by Forms USD Million (2021-2026)
  • Table 235. South Korea Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 236. Taiwan Liraglutide, by Application USD Million (2021-2026)
  • Table 237. Taiwan Liraglutide, by Forms USD Million (2021-2026)
  • Table 238. Taiwan Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 239. Australia Liraglutide, by Application USD Million (2021-2026)
  • Table 240. Australia Liraglutide, by Forms USD Million (2021-2026)
  • Table 241. Australia Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 242. Rest of Asia-Pacific Liraglutide, by Application USD Million (2021-2026)
  • Table 243. Rest of Asia-Pacific Liraglutide, by Forms USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 245. Europe Liraglutide, by Country USD Million (2021-2026)
  • Table 246. Europe Liraglutide, by Application USD Million (2021-2026)
  • Table 247. Europe Liraglutide, by Forms USD Million (2021-2026)
  • Table 248. Europe Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 249. Germany Liraglutide, by Application USD Million (2021-2026)
  • Table 250. Germany Liraglutide, by Forms USD Million (2021-2026)
  • Table 251. Germany Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 252. France Liraglutide, by Application USD Million (2021-2026)
  • Table 253. France Liraglutide, by Forms USD Million (2021-2026)
  • Table 254. France Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 255. Italy Liraglutide, by Application USD Million (2021-2026)
  • Table 256. Italy Liraglutide, by Forms USD Million (2021-2026)
  • Table 257. Italy Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 258. United Kingdom Liraglutide, by Application USD Million (2021-2026)
  • Table 259. United Kingdom Liraglutide, by Forms USD Million (2021-2026)
  • Table 260. United Kingdom Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 261. Netherlands Liraglutide, by Application USD Million (2021-2026)
  • Table 262. Netherlands Liraglutide, by Forms USD Million (2021-2026)
  • Table 263. Netherlands Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 264. Rest of Europe Liraglutide, by Application USD Million (2021-2026)
  • Table 265. Rest of Europe Liraglutide, by Forms USD Million (2021-2026)
  • Table 266. Rest of Europe Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 267. MEA Liraglutide, by Country USD Million (2021-2026)
  • Table 268. MEA Liraglutide, by Application USD Million (2021-2026)
  • Table 269. MEA Liraglutide, by Forms USD Million (2021-2026)
  • Table 270. MEA Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 271. Middle East Liraglutide, by Application USD Million (2021-2026)
  • Table 272. Middle East Liraglutide, by Forms USD Million (2021-2026)
  • Table 273. Middle East Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 274. Africa Liraglutide, by Application USD Million (2021-2026)
  • Table 275. Africa Liraglutide, by Forms USD Million (2021-2026)
  • Table 276. Africa Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 277. North America Liraglutide, by Country USD Million (2021-2026)
  • Table 278. North America Liraglutide, by Application USD Million (2021-2026)
  • Table 279. North America Liraglutide, by Forms USD Million (2021-2026)
  • Table 280. North America Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 281. United States Liraglutide, by Application USD Million (2021-2026)
  • Table 282. United States Liraglutide, by Forms USD Million (2021-2026)
  • Table 283. United States Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 284. Canada Liraglutide, by Application USD Million (2021-2026)
  • Table 285. Canada Liraglutide, by Forms USD Million (2021-2026)
  • Table 286. Canada Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 287. Mexico Liraglutide, by Application USD Million (2021-2026)
  • Table 288. Mexico Liraglutide, by Forms USD Million (2021-2026)
  • Table 289. Mexico Liraglutide, by Distribution Channel USD Million (2021-2026)
  • Table 290. Liraglutide Sales: by Application(ml)
  • Table 291. Liraglutide Sales Hospital , by Region ml (2021-2026)
  • Table 292. Liraglutide Sales Clinics , by Region ml (2021-2026)
  • Table 293. Liraglutide Sales Drug Store , by Region ml (2021-2026)
  • Table 294. Liraglutide Sales: by Forms(ml)
  • Table 295. Liraglutide Sales Pills , by Region ml (2021-2026)
  • Table 296. Liraglutide Sales Liquid , by Region ml (2021-2026)
  • Table 297. Liraglutide Sales: by Distribution Channel(ml)
  • Table 298. Liraglutide Sales Online , by Region ml (2021-2026)
  • Table 299. Liraglutide Sales Offline , by Region ml (2021-2026)
  • Table 300. South America Liraglutide Sales, by Country ml (2021-2026)
  • Table 301. South America Liraglutide Sales, by Application ml (2021-2026)
  • Table 302. South America Liraglutide Sales, by Forms ml (2021-2026)
  • Table 303. South America Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 304. Brazil Liraglutide Sales, by Application ml (2021-2026)
  • Table 305. Brazil Liraglutide Sales, by Forms ml (2021-2026)
  • Table 306. Brazil Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 307. Argentina Liraglutide Sales, by Application ml (2021-2026)
  • Table 308. Argentina Liraglutide Sales, by Forms ml (2021-2026)
  • Table 309. Argentina Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 310. Rest of South America Liraglutide Sales, by Application ml (2021-2026)
  • Table 311. Rest of South America Liraglutide Sales, by Forms ml (2021-2026)
  • Table 312. Rest of South America Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 313. Asia Pacific Liraglutide Sales, by Country ml (2021-2026)
  • Table 314. Asia Pacific Liraglutide Sales, by Application ml (2021-2026)
  • Table 315. Asia Pacific Liraglutide Sales, by Forms ml (2021-2026)
  • Table 316. Asia Pacific Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 317. China Liraglutide Sales, by Application ml (2021-2026)
  • Table 318. China Liraglutide Sales, by Forms ml (2021-2026)
  • Table 319. China Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 320. Japan Liraglutide Sales, by Application ml (2021-2026)
  • Table 321. Japan Liraglutide Sales, by Forms ml (2021-2026)
  • Table 322. Japan Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 323. India Liraglutide Sales, by Application ml (2021-2026)
  • Table 324. India Liraglutide Sales, by Forms ml (2021-2026)
  • Table 325. India Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 326. South Korea Liraglutide Sales, by Application ml (2021-2026)
  • Table 327. South Korea Liraglutide Sales, by Forms ml (2021-2026)
  • Table 328. South Korea Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 329. Taiwan Liraglutide Sales, by Application ml (2021-2026)
  • Table 330. Taiwan Liraglutide Sales, by Forms ml (2021-2026)
  • Table 331. Taiwan Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 332. Australia Liraglutide Sales, by Application ml (2021-2026)
  • Table 333. Australia Liraglutide Sales, by Forms ml (2021-2026)
  • Table 334. Australia Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 335. Rest of Asia-Pacific Liraglutide Sales, by Application ml (2021-2026)
  • Table 336. Rest of Asia-Pacific Liraglutide Sales, by Forms ml (2021-2026)
  • Table 337. Rest of Asia-Pacific Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 338. Europe Liraglutide Sales, by Country ml (2021-2026)
  • Table 339. Europe Liraglutide Sales, by Application ml (2021-2026)
  • Table 340. Europe Liraglutide Sales, by Forms ml (2021-2026)
  • Table 341. Europe Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 342. Germany Liraglutide Sales, by Application ml (2021-2026)
  • Table 343. Germany Liraglutide Sales, by Forms ml (2021-2026)
  • Table 344. Germany Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 345. France Liraglutide Sales, by Application ml (2021-2026)
  • Table 346. France Liraglutide Sales, by Forms ml (2021-2026)
  • Table 347. France Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 348. Italy Liraglutide Sales, by Application ml (2021-2026)
  • Table 349. Italy Liraglutide Sales, by Forms ml (2021-2026)
  • Table 350. Italy Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 351. United Kingdom Liraglutide Sales, by Application ml (2021-2026)
  • Table 352. United Kingdom Liraglutide Sales, by Forms ml (2021-2026)
  • Table 353. United Kingdom Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 354. Netherlands Liraglutide Sales, by Application ml (2021-2026)
  • Table 355. Netherlands Liraglutide Sales, by Forms ml (2021-2026)
  • Table 356. Netherlands Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 357. Rest of Europe Liraglutide Sales, by Application ml (2021-2026)
  • Table 358. Rest of Europe Liraglutide Sales, by Forms ml (2021-2026)
  • Table 359. Rest of Europe Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 360. MEA Liraglutide Sales, by Country ml (2021-2026)
  • Table 361. MEA Liraglutide Sales, by Application ml (2021-2026)
  • Table 362. MEA Liraglutide Sales, by Forms ml (2021-2026)
  • Table 363. MEA Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 364. Middle East Liraglutide Sales, by Application ml (2021-2026)
  • Table 365. Middle East Liraglutide Sales, by Forms ml (2021-2026)
  • Table 366. Middle East Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 367. Africa Liraglutide Sales, by Application ml (2021-2026)
  • Table 368. Africa Liraglutide Sales, by Forms ml (2021-2026)
  • Table 369. Africa Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 370. North America Liraglutide Sales, by Country ml (2021-2026)
  • Table 371. North America Liraglutide Sales, by Application ml (2021-2026)
  • Table 372. North America Liraglutide Sales, by Forms ml (2021-2026)
  • Table 373. North America Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 374. United States Liraglutide Sales, by Application ml (2021-2026)
  • Table 375. United States Liraglutide Sales, by Forms ml (2021-2026)
  • Table 376. United States Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 377. Canada Liraglutide Sales, by Application ml (2021-2026)
  • Table 378. Canada Liraglutide Sales, by Forms ml (2021-2026)
  • Table 379. Canada Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 380. Mexico Liraglutide Sales, by Application ml (2021-2026)
  • Table 381. Mexico Liraglutide Sales, by Forms ml (2021-2026)
  • Table 382. Mexico Liraglutide Sales, by Distribution Channel ml (2021-2026)
  • Table 383. Research Programs/Design for This Report
  • Table 384. Key Data Information from Secondary Sources
  • Table 385. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Liraglutide: by Application USD Million (2015-2020)
  • Figure 5. Global Liraglutide: by Forms USD Million (2015-2020)
  • Figure 6. Global Liraglutide: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Liraglutide Share (%), by Country
  • Figure 8. Asia Pacific Liraglutide Share (%), by Country
  • Figure 9. Europe Liraglutide Share (%), by Country
  • Figure 10. MEA Liraglutide Share (%), by Country
  • Figure 11. North America Liraglutide Share (%), by Country
  • Figure 12. Global Liraglutide: by Application ml (2015-2020)
  • Figure 13. Global Liraglutide: by Forms ml (2015-2020)
  • Figure 14. Global Liraglutide: by Distribution Channel ml (2015-2020)
  • Figure 15. South America Liraglutide Share (%), by Country
  • Figure 16. Asia Pacific Liraglutide Share (%), by Country
  • Figure 17. Europe Liraglutide Share (%), by Country
  • Figure 18. MEA Liraglutide Share (%), by Country
  • Figure 19. North America Liraglutide Share (%), by Country
  • Figure 20. Global Liraglutide share by Players 2020 (%)
  • Figure 21. Global Liraglutide share by Players (Top 3) 2020(%)
  • Figure 22. Global Liraglutide share by Players (Top 5) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. HEC Pharm (China) Revenue, Net Income and Gross profit
  • Figure 25. HEC Pharm (China) Revenue: by Geography 2020
  • Figure 26. Teva (Israel) Revenue, Net Income and Gross profit
  • Figure 27. Teva (Israel) Revenue: by Geography 2020
  • Figure 28. Bachem (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Bachem (Switzerland) Revenue: by Geography 2020
  • Figure 30. Bharat Pharmaceuticals (India) Revenue, Net Income and Gross profit
  • Figure 31. Bharat Pharmaceuticals (India) Revenue: by Geography 2020
  • Figure 32. Shenzhen JYMed Technology (China) Revenue, Net Income and Gross profit
  • Figure 33. Shenzhen JYMed Technology (China) Revenue: by Geography 2020
  • Figure 34. WuXi AppTec Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 35. WuXi AppTec Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 36. AmbioPharm, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 37. AmbioPharm, Inc (United States) Revenue: by Geography 2020
  • Figure 38. Rochem International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Rochem International Inc. (United States) Revenue: by Geography 2020
  • Figure 40. ALP Pharm (China) Revenue, Net Income and Gross profit
  • Figure 41. ALP Pharm (China) Revenue: by Geography 2020
  • Figure 42. Viruj Pharma (India) Revenue, Net Income and Gross profit
  • Figure 43. Viruj Pharma (India) Revenue: by Geography 2020
  • Figure 44. Global Liraglutide: by Application USD Million (2021-2026)
  • Figure 45. Global Liraglutide: by Forms USD Million (2021-2026)
  • Figure 46. Global Liraglutide: by Distribution Channel USD Million (2021-2026)
  • Figure 47. South America Liraglutide Share (%), by Country
  • Figure 48. Asia Pacific Liraglutide Share (%), by Country
  • Figure 49. Europe Liraglutide Share (%), by Country
  • Figure 50. MEA Liraglutide Share (%), by Country
  • Figure 51. North America Liraglutide Share (%), by Country
  • Figure 52. Global Liraglutide: by Application ml (2021-2026)
  • Figure 53. Global Liraglutide: by Forms ml (2021-2026)
  • Figure 54. Global Liraglutide: by Distribution Channel ml (2021-2026)
  • Figure 55. South America Liraglutide Share (%), by Country
  • Figure 56. Asia Pacific Liraglutide Share (%), by Country
  • Figure 57. Europe Liraglutide Share (%), by Country
  • Figure 58. MEA Liraglutide Share (%), by Country
  • Figure 59. North America Liraglutide Share (%), by Country
List of companies from research coverage that are profiled in the study
  • HEC Pharm (China)
  • Teva (Israel)
  • Bachem (Switzerland)
  • Bharat Pharmaceuticals (India)
  • Shenzhen JYMed Technology (China)
  • WuXi AppTec Co., Ltd. (China)
  • AmbioPharm, Inc (United States)
  • Rochem International Inc. (United States)
  • ALP Pharm (China)
  • Viruj Pharma (India)
Select User Access Type

Key Highlights of Report


Jun 2021 245 Pages 71 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Liraglutide Quantitative research analysis
Global Liraglutide Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing preference for health care" is seen as one of major growth factors of Liraglutide Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Liraglutide Report?

Have a Query? Click Here

Other Related Reports

Dimethylaminopropylamine Comprehensive Study by Type (Intermittent production process, Continuous production process), Application (Daily Chemical Products, Epoxy, Organic synthesis intermediates, Ot...
$ 3650
Natural Rubber Latex Comprehensive Study by Type (Ribbed Smoked Sheet (RSS), Technically Specified Rubber (TSR), Reclaimed Rubber, Solid Block Rubber), Application (Medical Gloves, Latex Tubing, Cons...
$ 3650
Nucleotide Comprehensive Study by Application (Lab, Food, Feed, Others), End Users (Pharmaceuticals, Diagnostics Research, Food & Beverage Additive, Animal Feed Additive), Technology (Taqman Allelic ...
$ 3450
Fulvic Acid Comprehensive Study by Type (Fulvates Fulvic Acid, Free-form Fulvic Acid), Application (Pharmaceuticals, Fertilizers, Supplements, Others), Form (Powder, Liquid), Distribution Channels (O...
$ 3350
Natural Menthol Comprehensive Study by Type (Food Grade Menthol, Pharmaceutical Grade Menthol), Application (Pharmaceuticals, Confectionaries, Tobacco, Oral Hygiene, Other), Pack Size (Below 25 gm, 5...
$ 3450
Oregano Oil Comprehensive Study by Type (Organic Oregano Oil, Conventional Oregano Oil), Application (Cosmetic, Pharmaceutical, Food and Beverage, Others), Sales Channel (Online, Offline), Extraction...
$ 3800